期刊文献+

SLC7A5对胃癌细胞增殖的影响及其病理学意义 被引量:1

Effect of SLC7A5 on cell proliferation in gastric cancer and its pathologic significance
原文传递
导出
摘要 目的:研究胃癌中SLC7A5转录和表达的特点,探讨SLC7A5对胃癌细胞增殖的影响及其在胃癌发生、发展中的临床意义。方法:应用免疫组化法检测52对临床采集的胃癌组织及相应的癌旁组织中SLC7A5的表达情况;分析4株胃癌细胞(SGC-7901、MKN-45、MGC-803和CRL-5974)中SLC7A5转录及表达水平与永生化胃黏膜细胞GES-1间的差异;结合临床病理指标,分析SLC7A5在胃癌组织中的表达水平与各项临床病理特征间的相关性;并应用pGU6/GFP/Neo/shRNA-SLC7A5质粒载体转染胃癌SGC-7901细胞,下调SLC7A5表达,通过CCK8检测及流式细胞术检测分析SLC7A5对胃癌细胞增殖和细胞周期的影响。结果:SLC7A5在胃癌组织和细胞中的表达上调,且其表达水平与胃癌肿瘤的直径、局部浸润深度、淋巴结转移及TNM分期进展显著相关;而下调胃癌SGC-7901细胞SLC7A5表达,可显著减弱胃癌细胞增殖能力,并将细胞周期阻滞于G0/G1期。结论:SLC7A5可促进胃癌细胞增殖,与其肿瘤直径、局部浸润深度、淋巴结转移及TNM分期等临床病理特征相关,可作为分子标志物评价胃癌的生物学行为,并可能成为胃癌诊断和防治中的新靶点。 Objective:To investigate the transcription and expression of SLC7A5 in GC tissue and cell lines,and analyze the influence of SLC7A5 on GC cell proliferation and its clinicopathologic significance.Methods:Levels of SLC7A5 expression in GC tissues and match paired non-cancerous tissues from 52 patients were detected by immnohistochemistry analysis.Differences in transcription and protein expression of SLC7A5 between GC cell lines(SGC-7901,MKN-45,MGC-803 and CRL-5974) and human gastric epithelial immortalized GES-1 cells were surveyed.Correlations between the expression of SLC7A5 and the clinicopathologic features of GC were analyzed.GC SGC-7901 cells,in which expression of SLC7A5 was down-regulated by pGU6/ GFP/Neo/sh-RNA,were studied for cell proliferation ability and cell cycle by applying CCK assay and flow cytometry.Results:The expression of SLC7A5 in GC tissues was up-regulated and associated significantly with tumor size,local invasion,lymph node metastasis and advanced TNM stage.Down-regulation of SLC7A5 expression in SGC-7901 cells inhibited the ability of cell proliferation,along with significant G0/G1 cell cycle arrest.Conclusions:SLC7A5 confers GC cells with greater proliferation and is associated with the clinicopathologic features of GC,including tumor size,local invasion,lymph node metastasis and TNM stage.SLC7A5 could be a biomarker for predicting GC biological behavior,and perhaps become a new target for GC diagnosis and treatment.
出处 《诊断学理论与实践》 2013年第3期284-289,共6页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金(30900670 81272749) 上海交通大学医学院科技基金(12XJ10049)
关键词 胃癌 SLC7A5 细胞增殖 临床病理 Gastric cancer SLC7A5 Cell proliferation Clinicopathology
  • 相关文献

参考文献22

  • 1Kamangar F, Dores GM, Anderson WF. Patterns ofcancer incidence, mortality, and prevalence across fivecontinents: defining priorities to reduce cancer disparitiesin different geographic regions of the world[J]. J Clin Oncol,2006,24(14):2137-2150.
  • 2Bickenbach K, Strong VE. Comparisons of Gastric CancerTreatments: East vs. West[J]. J Gastric Cancer,2012,12(2):55-62.
  • 3Jemal A, Bray F, Center MM, et al. Global cancerstatistics[J]. CA Cancer J Clin,2011,61(2):69-90.
  • 4Kampschder GH, Fujii A, Masuda Y. Gastric cancerdetected by mass survey. Comparison between masssurvey and outpatient detection[J]. Scand J Gastroenterol,1989,24(7):813-817.
  • 5Baker LA, Allis CD, Wang GG. PHD fingers in humandiseases: disorders arising from misinterpreting epigeneticmarks[J]. Mutat Res,2008,647(1-2):3-12.
  • 6Yurchenko V, Constant S, Bukrinsky M. Dealing with thefamily: CD147 interactions with cyclophilins [J].Immunology,2006,117(3):301-309.
  • 7刘雷,郭磊,王志威,等.新型标志物HAM8G/CD147在大样本胃癌组织中的表达研究[J].诊断理论与实践,2012,11(1):42-46.
  • 8Segawa H, Fukasawa Y, Miyamoto K,et al. Identificationand functional characterization of a Na +-independentneutral amino acid transporter with broad substrateselectivity[J]. J Biol Chem, 1999,274(28): 19745-19751.
  • 9Kanai Y, Segawa H,Miyamoto Ki, et al. Expressioncloning and characterization of a transporter for largeneutral amino acids activated by the heavy chain of 4F2antigen (CD98)[J]. J Biol Chem,1998,273 (37):23629-23632.
  • 10Mannion BA, Kolesnikova TV, Lin SH, et al. The lightchain of CD98 is identified as E16/TA1 protein [J]. J BiolChem, 1998,273(50):33127-33129.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部